Profile
Main Sequence Ventures is a deep tech investor based in Sydney, Australia. Founded in collaboration with CSIRO, the firm focuses on translating Australian publicly-funded research into commercial outcomes. The team is composed of experienced investors and industry experts dedicated to tackling significant global challenges through innovation.
Main Sequence Ventures invests in sectors such as space, healthcare, industrial productivity, and food security. They typically invest in early to late-stage companies, with a focus on transformative technologies. The firm manages the CSIRO Innovation Fund, which supports ventures aiming to bridge the gap between research and market application.
Notable investments by Main Sequence Ventures include Cortisonic - a healthcare technology company, Andromeda - a robotics firm, Currus - an industrial productivity startup, Breaker - a space technology company, ElectraLith - a clean energy innovator, and Deteqt - a company focused on advanced perception technologies.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.